Chemours: We're Back Down To Trough And A 'BUY'

Sep. 01, 2024 4:04 PM ETThe Chemours Company (CC) StockCC8 Comments

Summary

  • Chemours faces operational challenges and accounting irregularities, but its position in refrigerants and crucial chemicals offers significant growth potential, outweighing current risks.
  • Despite a 10% stock drop, 2Q24 results show resilience with $1.5B in sales and strong performance in the Titanium and Opteon segments.
  • The company's liquidity remains strong, with over $1.5B available, and ongoing cost-saving measures are expected to drive future growth.
  • Maintaining a "Buy" rating, I believe Chemours is undervalued with a potential 70% RoR by 2026, despite its speculative nature.

Chemours headquarters in Wilmington, Delaware, USA

JHVEPhoto

Dear readers/followers,

When I last covered Chemours (NYSE:CC) the company had seen some irregularities in its operations in accounting. In my last article, I saw a positive rate of return for the investment I made a few months

The company discussed in this article is only one potential investment in the sector. Members of iREIT on Alpha get access to investment ideas with upsides that I view as significantly higher/better than this one. Consider subscribing and learning more here.

This article was written by

34.3K Followers

Wolf Report is a senior analyst and private portfolio manager with over 10 years of generating value ideas in European and North American markets.

He is a contributing author and analyst for the investing group iREIT®+HOYA Capital and Wide Moat Research LLC where in addition to the U.S. market, he covers the markets of Scandinavia, Germany, France, UK, Italy, Spain, Portugal and Eastern Europe in search of reasonably valued stock ideas.

Learn more

Analyst’s Disclosure:I/we have a beneficial long position in the shares of CC either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

While this article may sound like financial advice, please observe that the author is not a CFA or in any way licensed to give financial advice. It may be structured as such, but it is not financial advice. Investors are required and expected to do their own due diligence and research prior to any investment. Short-term trading, options trading/investment and futures trading are potentially extremely risky investment styles. They generally are not appropriate for someone with limited capital, limited investment experience, or a lack of understanding for the necessary risk tolerance involved. I own the European/Scandinavian tickers (not the ADRs) of all European/Scandinavian companies listed in my articles. I own the Canadian tickers of all Canadian stocks i write about. Please note that investing in European/Non-US stocks comes with withholding tax risks specific to the company's domicile as well as your personal situation. Investors should always consult a tax professional as to the overall impact of dividend witholding taxes and ways to mitigate these.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

About CC Stock

SymbolLast Price% Chg
Market Cap
PE
Yield
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on CC

Related Stocks

SymbolLast Price% Chg
CC
--